TACSTD2 and colorectal carcinoma: This effect achieved via the ERK1/2 pathway axis leads to an overexpression of tumor-associated calcium signal transduction protein 2 (TROP-2), a transmembrane glycoprotein expressed in many types of human epithelial tumors, including CRC [92].